{"transactions":[{"id":773865,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:36:33.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":27535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported, 139 shares acquired by the reporting person on October 31, 2025 under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time, the \"ESPP\") and 119 shares acquired by the reporting person on April 30, 2026 under the ESPP."}],"balance_after":32936,"source":{"system":"sec-edgar","filing":"0000313143-26-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000047/form4.xml","form_type":"4"}},{"id":773864,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:36:33.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":546,"price":56.29,"value":30734.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units (\"RSUs\") previously reported in Table I."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes unvested RSUs previously reported, 139 shares acquired by the reporting person on October 31, 2025 under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time, the \"ESPP\") and 119 shares acquired by the reporting person on April 30, 2026 under the ESPP."}],"balance_after":5401,"source":{"system":"sec-edgar","filing":"0000313143-26-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000047/form4.xml","form_type":"4"}},{"id":1141356,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-20T21:24:29.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":12317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in annual increments of 25% beginning on the first anniversary of the date of grant."}],"balance_after":12317,"derivative":{"exercise_price":70.31,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":12317},"source":{"system":"sec-edgar","filing":"0001127602-25-015063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015063/form4.xml","form_type":"4"}},{"id":1141355,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":46226,"kind":"person","name":"Chan Frank","position":1,"cik":"0002061743","reported_name":"Chan Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:24:29.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5689,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":5689,"source":{"system":"sec-edgar","filing":"0001127602-25-015063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225015063/form4.xml","form_type":"4"}}]}